Harrington L B, Marck B T, Wiggins K L, McKnight B, Heckbert S R, Woods N F, LaCroix A Z, Blondon M, Psaty B M, Rosendaal F R, Matsumoto A M, Smith N L
Department of Epidemiology, University of Washington, Seattle, WA, USA.
Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
J Thromb Haemost. 2017 Jan;15(1):80-90. doi: 10.1111/jth.13554. Epub 2017 Jan 8.
Essentials Endogenous hormone levels' influence on hemostatic factor levels is not fully characterized. We tested for associations of endogenous hormone with hemostatic factor levels in postmenopause. Estrone levels were inversely associated with the natural anticoagulant, protein S antigen. Dehydroepiandrosterone sulfate levels were inversely associated with thrombin generation.
Background Oral use of exogenous estrogen/progestin alters hemostatic factor levels. The influence of endogenous hormones on these levels is incompletely characterized. Objectives Our study aimed to test whether, among postmenopausal women, high levels of estradiol (E2), estrone (E1), testosterone (T), dehydroepiandrosterone sulfate (DHEAS), dehydroepiandrosterone (DHEA), and androstenedione, and low levels of sex hormone-binding globulin (SHBG), are positively associated with measures of thrombin generation (TG), a normalized activated protein C sensitivity ratio (nAPCsr), and factor VII activity (FVIIc), and negatively associated with antithrombin activity (ATc) and total protein S antigen (PSAg). Methods This Heart and Vascular Health study cross-sectional analysis included 131 postmenopausal women without a prior venous thrombosis who were not currently using hormone therapy. Adjusted mean differences in TG, nAPCsr, FVIIc, ATc and PSAg levels associated with differences in hormone levels were estimated using multiple linear regression. We measured E2, E1, total T, DHEAS, DHEA and androstenedione levels by mass spectrometry, SHBG levels by immunoassay, and calculated the level of free T. Results One picogram per milliliter higher E1 levels were associated with 0.24% lower PSAg levels (95% Confidence Interval [CI]: -0.35, -0.12) and 1 μg mL higher DHEAS levels were associated with 40.8 nm lower TG peak values (95% CI: -59.5, -22.2) and 140.7 nm×min lower TG endogenous thrombin potential (ETP) (95% CI: -212.1, -69.4). After multiple comparisons correction, there was no evidence for other associations. Conclusions As hypothesized, higher E1 levels were associated with lower levels of the natural anticoagulant PSAg. Contrary to hypotheses, higher DHEAS levels were associated with differences in TG peak and ETP that suggest less generation of thrombin.
内源性激素水平对止血因子水平的影响尚未完全明确。我们检测了绝经后内源性激素与止血因子水平之间的关联。雌酮水平与天然抗凝剂蛋白S抗原呈负相关。硫酸脱氢表雄酮水平与凝血酶生成呈负相关。
背景 口服外源性雌激素/孕激素会改变止血因子水平。内源性激素对这些水平的影响尚未完全明确。目的 我们的研究旨在测试在绝经后女性中,高水平的雌二醇(E2)、雌酮(E1)、睾酮(T)、硫酸脱氢表雄酮(DHEAS)、脱氢表雄酮(DHEA)和雄烯二酮,以及低水平的性激素结合球蛋白(SHBG),是否与凝血酶生成(TG)、标准化活化蛋白C敏感率(nAPCsr)和因子VII活性(FVIIc)的指标呈正相关,与抗凝血酶活性(ATc)和总蛋白S抗原(PSAg)呈负相关。方法 这项心脏和血管健康研究的横断面分析纳入了131名未发生过静脉血栓且目前未使用激素治疗的绝经后女性。使用多元线性回归估计与激素水平差异相关的TG、nAPCsr、FVIIc、ATc和PSAg水平的校正平均差异。我们通过质谱法测量E2、E1、总T、DHEAS、DHEA和雄烯二酮水平,通过免疫测定法测量SHBG水平,并计算游离T水平。结果 E1水平每升高1皮克/毫升,PSAg水平降低0.24%(95%置信区间[CI]:-0.35,-0.12);DHEAS水平每升高1微克/毫升,TG峰值降低40.8纳米(95%CI:-59.5,-22.2),TG内源性凝血酶潜力(ETP)降低140.7纳米×分钟(95%CI:-212.1,-69.4)。经过多重比较校正后,没有证据支持其他关联。结论 如假设的那样,较高的E1水平与天然抗凝剂PSAg的较低水平相关。与假设相反,较高的DHEAS水平与TG峰值和ETP的差异相关,这表明凝血酶生成较少。